Published in World J Biol Chem on May 26, 2010
Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus. Sci Rep (2013) 0.83
Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic. Semin Respir Crit Care Med (2013) 0.81
Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter. Arch Med Res (2015) 0.75
Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Pattern recognition receptors and inflammation. Cell (2010) 21.05
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science (2001) 18.43
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 15.02
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med (2009) 14.48
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
1918 Influenza: the mother of all pandemics. Emerg Infect Dis (2006) 12.11
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol (1993) 10.22
Initial genetic characterization of the 1918 "Spanish" influenza virus. Science (1997) 10.17
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med (2002) 9.47
Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med (2009) 8.99
Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science (2009) 8.61
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (2009) 7.80
Influenza pandemics of the 20th century. Emerg Infect Dis (2006) 7.19
The multifunctional NS1 protein of influenza A viruses. J Gen Virol (2008) 6.87
Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science (2010) 6.10
Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis (2009) 5.56
The pathology of influenza virus infections. Annu Rev Pathol (2008) 5.37
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol (2006) 4.88
Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol (2006) 4.74
Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci U S A (1988) 4.41
The evolution of epidemic influenza. Nat Rev Genet (2007) 4.12
A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A (2008) 3.99
Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med (2010) 3.91
Cell-mediated protection in influenza infection. Emerg Infect Dis (2006) 3.62
Historical perspective--Emergence of influenza A (H1N1) viruses. N Engl J Med (2009) 3.53
Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep (2009) 3.41
Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog (2008) 3.37
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
Influenza and the challenge for immunology. Nat Immunol (2006) 3.24
Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs. J Gen Virol (2009) 3.09
Pathology of human influenza revisited. Vaccine (2008) 2.71
Evolving complexities of influenza virus and its receptors. Trends Microbiol (2008) 2.49
Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev (2008) 2.41
Swine influenza a outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis (2006) 2.40
Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu Rev Microbiol (2008) 2.29
Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc Natl Acad Sci U S A (2001) 2.25
Severe encephalopathy with swine origin influenza A H1N1 infection in childhood: case reports. Neurology (2010) 2.10
From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza. Nat Rev Microbiol (2004) 1.98
Animal models for the study of influenza pathogenesis and therapy. Antiviral Res (2009) 1.90
The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med (2009) 1.86
Preexisting immunity to pandemic (H1N1) 2009. Emerg Infect Dis (2009) 1.85
Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol (2010) 1.79
Probiotics and immunity. J Gastroenterol (2009) 1.79
Estimating influenza-associated deaths in the United States. Am J Public Health (2009) 1.73
Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol (2009) 1.72
Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res (2010) 1.70
Changing selective pressure during antigenic changes in human influenza H3. PLoS Pathog (2008) 1.61
Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol (2009) 1.58
Probiotic immunomodulation in health and disease. J Nutr (2000) 1.56
Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. MMWR Morb Mortal Wkly Rep (2010) 1.54
M2e-based universal influenza A vaccine. Vaccine (2009) 1.52
Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine (2009) 1.51
Research and development of universal influenza vaccines. Microbes Infect (2010) 1.49
Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. J Infect Dis (2010) 1.43
Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition (2007) 1.34
In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrob Agents Chemother (2010) 1.29
The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J (2007) 1.24
Viruses are essential agents within the roots and stem of the tree of life. J Theor Biol (2009) 1.21
A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine (2009) 1.18
Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol (2004) 1.18
Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. J Interferon Cytokine Res (2009) 1.17
Influenza vaccines. Vaccine (2009) 1.17
Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J Allergy Clin Immunol (1998) 1.16
Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. J Antimicrob Chemother (2010) 1.15
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration. Antimicrob Agents Chemother (2010) 1.09
The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examination. Jpn J Infect Dis (2010) 1.09
Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults. J Nutr (2006) 1.08
Reverse genetics of influenza virus. Virology (2001) 1.05
Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064. Clin Diagn Lab Immunol (1999) 1.02
Severe H1N1-Associated acute respiratory distress syndrome: A case series. Am J Med (2010) 0.98
Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int Immunopharmacol (2009) 0.94
Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosis. J Gen Virol (2002) 0.94
Neuropathogenesis of influenza virus infection in mice. Microbes Infect (2001) 0.93
Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice. Cancer Immunol Immunother (2000) 0.85
Augmentation of anti-influenza virus hemagglutinin antibody production by Peyer's patch cells with Bifidobacterium breve YIT4064. Clin Diagn Lab Immunol (1994) 0.83
Immunopotentiating activity of nigerooligosaccharides for the T helper 1-like immune response in mice. Biosci Biotechnol Biochem (1999) 0.82
Sudden death of a patient with pandemic influenza (A/H1N1pdm) virus infection by acute respiratory distress syndrome. Jpn J Infect Dis (2010) 0.79
Thinking about broadly cross-reactive vaccines. Clin Pharmacol Ther (2009) 0.78
Natural genome-editing competences of viruses. Acta Biotheor (2007) 0.77
Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA (2002) 4.32
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol (2012) 3.57
Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension (2004) 2.10
Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity (2004) 1.93
Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood (2005) 1.67
Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest (2003) 1.65
Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol (2008) 1.62
New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs. Clin Chem (2009) 1.59
Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci U S A (2002) 1.55
Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization. Arterioscler Thromb Vasc Biol (2011) 1.49
TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J Biol Chem (2004) 1.42
Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig. Transplantation (2002) 1.40
Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2003) 1.34
Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer. Am J Pathol (2006) 1.30
Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2011) 1.29
Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthritis Rheum (2009) 1.20
Enhanced local production of osteopontin in rheumatoid joints. J Rheumatol (2002) 1.20
High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am J Respir Crit Care Med (2003) 1.19
Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circ Res (2011) 1.12
Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis. Arthritis Rheum (2002) 1.11
Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration. Blood (2012) 1.06
Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J Immunol (2009) 1.04
Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway. J Mol Cell Cardiol (2009) 0.99
Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin. J Exp Med (2007) 0.99
Integrin α9β1 in airway smooth muscle suppresses exaggerated airway narrowing. J Clin Invest (2012) 0.98
Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation (2003) 0.97
Osteopontin regulates development and function of invariant natural killer T cells. Proc Natl Acad Sci U S A (2008) 0.97
Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets (2010) 0.96
Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. Int Immunol (2003) 0.95
Corneal wound healing in an osteopontin-deficient mouse. Invest Ophthalmol Vis Sci (2008) 0.95
The differential amino acid requirement within osteopontin in alpha4 and alpha9 integrin-mediated cell binding and migration. Matrix Biol (2008) 0.95
Molecular dynamics of STAT3 on IL-6 signaling pathway in living cells. Biochem Biophys Res Commun (2004) 0.94
Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. J Mol Cell Cardiol (2004) 0.94
Functional role of death-associated protein 3 (DAP3) in anoikis. J Biol Chem (2004) 0.92
Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome. Arthritis Res Ther (2012) 0.92
Mechanism of macrophage activation by chitin derivatives. J Vet Med Sci (2005) 0.91
CSF-1-dependent red pulp macrophages regulate CD4 T cell responses. J Immunol (2011) 0.91
Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium. Lab Invest (2007) 0.91
Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis. Circulation (2004) 0.91
ATM-mediated DNA damage signals mediate immune escape through integrin-αvβ3-dependent mechanisms. Cancer Res (2011) 0.90
Regulatory role of DC-derived osteopontin in systemic allergen sensitization. Eur J Immunol (2009) 0.90
α9β1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation. J Immunol (2011) 0.90
Circulating interleukin-18 and osteopontin are useful to evaluate disease activity in patients with tuberculosis. Cytokine (2005) 0.90
Penicillium marneffei causes osteopontin-mediated production of interleukin-12 by peripheral blood mononuclear cells. Infect Immun (2002) 0.90
Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications. Br J Haematol (2003) 0.89
Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic Res (2007) 0.89
Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model. Transplantation (2003) 0.88
LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma. Anticancer Res (2007) 0.88
Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction. World J Biol Chem (2010) 0.88
Osteopontin affects the persistence of beta-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms. Int Immunol (2004) 0.88
In vitro and in vivo effects of the overexpression of osteopontin on osteoblast differentiation using a recombinant adenoviral vector. J Biochem (2004) 0.87
Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway. Cardiovasc Res (2003) 0.87
The role of osteopontin in tendon tissue remodeling after denervation-induced mechanical stress deprivation. Matrix Biol (2006) 0.87
Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences. J Cell Biochem (2002) 0.87
Enhanced resistance to herpes simplex virus type 1 infection in transgenic mice expressing a soluble form of herpesvirus entry mediator. Virology (2004) 0.86
Effect of osteopontin alleles on beta-glucan-induced granuloma formation in the mouse liver. Am J Pathol (2004) 0.86
Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. Biochem Biophys Res Commun (2004) 0.85
Dimeric but not monomeric soluble CD40 prolongs allograft survival and generates regulatory T cells that inhibit CTL function. Transplantation (2005) 0.85
Prevention of acute lung allograft rejection in rat by CTLA4Ig. Am J Transplant (2002) 0.85
Development of atherosclerosis in osteopontin transgenic mice. Heart Vessels (2002) 0.85
Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney. Am J Physiol Renal Physiol (2011) 0.84
Osteopontin participates in Th1-mediated host resistance against nonlethal malaria parasite Plasmodium chabaudi chabaudi infection in mice. Infect Immun (2006) 0.84
Impaired angiogenic response in the corneas of mice lacking osteopontin. Invest Ophthalmol Vis Sci (2009) 0.84
Crucial role of the cryptic epitope SLAYGLR within osteopontin in renal crystal formation of mice. J Bone Miner Res (2011) 0.84
Down-regulation of cathepsin K in synovium leads to progression of osteoarthritis in rabbits. Arthritis Rheum (2009) 0.83
Osteopontin aggravates experimental autoimmune uveoretinitis in mice. J Immunol (2007) 0.83
Differential requirement for the CD40-CD154 costimulatory pathway during Th cell priming by CD8 alpha+ and CD8 alpha- murine dendritic cell subsets. J Immunol (2004) 0.83
NMR characterization of intramolecular interaction of osteopontin, an intrinsically disordered protein with cryptic integrin-binding motifs. Biochem Biophys Res Commun (2010) 0.83
Osteopontin is dispensable for protection against high load systemic fungal infection. Int Immunopharmacol (2008) 0.82
Severe Infection With Avian Influenza A Virus is Associated With Delayed Immune Recovery in Survivors. Medicine (Baltimore) (2016) 0.82
Regulatory roles of IL-2 and IL-4 in H4/inducible costimulator expression on activated CD4+ T cells during Th cell development. J Immunol (2003) 0.82
Blockade of the 4-1BB pathway attenuates graft arterial disease in cardiac allografts. Int Heart J (2008) 0.82
Osteopontin has a crucial role in osteoclast-like multinucleated giant cell formation. J Cell Biochem (2014) 0.82
Osteopontin is critical to determine symptom severity of influenza through the regulation of NK cell population. Biochem Biophys Res Commun (2011) 0.82
Resistance to pseudorabies virus infection in transformed cell lines expressing a soluble form of porcine herpesvirus entry mediator C. J Gen Virol (2004) 0.81
Persistent hyperplastic primary vitreous in transgenic mice expressing IE180 of the pseudorabies virus. Invest Ophthalmol Vis Sci (2005) 0.81
Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody. Int Immunopharmacol (2007) 0.81
Osteopontin small interfering RNA protects mice from fulminant hepatitis. Hum Gene Ther (2007) 0.81
Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis. J Mol Cell Cardiol (2002) 0.81
Suppression of the bacterial antigen-specific T cell response and the dendritic cell migration to the lymph nodes by osteopontin. Microbiol Immunol (2007) 0.81
Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA. Exp Eye Res (2009) 0.81
Attenuation of graft arterial disease by manipulation of the LIGHT pathway. Arterioscler Thromb Vasc Biol (2004) 0.81
Transgenic mice expressing a soluble form of porcine nectin-1/herpesvirus entry mediator C as a model for pseudorabies-resistant livestock. Proc Natl Acad Sci U S A (2004) 0.81
Adenovirus-mediated gene transfer of ICOSIg fusion protein ameliorates ongoing experimental autoimmune myocarditis. Hum Gene Ther (2003) 0.81
Functions and development of red pulp macrophages. Microbiol Immunol (2015) 0.80
Osteopontin regulates interleukin-17 production in hepatitis. Cytokine (2012) 0.80
Suppression of neointimal hyperplasia after vascular injury by blocking 4-1BB/4-1BB ligand pathway. J Med Dent Sci (2008) 0.80
Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress. Proc Natl Acad Sci U S A (2014) 0.80
Osteopontin modulates the generation of memory CD8+ T cells during influenza virus infection. J Immunol (2011) 0.80
Local administration of soluble CD40:Fc to the salivary glands of non-obese diabetic mice does not ameliorate autoimmune inflammation. PLoS One (2012) 0.79
Blockade of interaction of alpha9 integrin with its ligands hinders the formation of granulation in cutaneous wound healing. Lab Invest (2010) 0.79
Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy. Nephron Extra (2012) 0.79
Effect of osteopontin on diarrhea duration and innate immunity in suckling mice infected with a murine rotavirus. Viral Immunol (2009) 0.79
Tear osteopontin levels in patients with allergic conjunctival diseases. Graefes Arch Clin Exp Ophthalmol (2002) 0.79
Intrinsic and extrinsic manipulation of B7/CTLA-4 interaction for induction of anti-tumor immunity against osteosarcoma cells. Anticancer Res (2003) 0.79
Cerebellar pathology in transgenic mice expressing the pseudorabies virus immediate-early protein IE180. Eur J Neurosci (2008) 0.78
Mice with osteopontin deletion remain predisposed to collagen-induced arthritis. Arthritis Rheum (2004) 0.78
Decreased Osteopontin Expression as a Reliable Prognostic Indicator of Improvement in Pulmonary Tuberculosis: Impact of the Level of Interferon-x03B3;-Inducible Protein 10. Cell Physiol Biochem (2015) 0.78
Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model. Surg Today (2010) 0.77
Concurrent induction of T-cell activation and apoptosis of osteosarcoma cells by adenovirus-mediated B7-1/Fas chimeric gene transfer. Cancer Gene Ther (2003) 0.77